Response to PD‐1 blockade in a patient with mucosal melanoma of the middle ear: Case report

Affiliations

Hiroki Komatsuda: Department of Otolaryngology‐Head & Neck Surgery Asahikawa Medical University Asahikawa Japan
Takumi Kumai: Department of Otolaryngology‐Head & Neck Surgery Asahikawa Medical University Asahikawa Japan
Seigo Ueda: Department of Otolaryngology‐Head & Neck Surgery Asahikawa Medical University Asahikawa Japan
Yui Hirata‐Nozaki: Department of Otolaryngology‐Head & Neck Surgery Asahikawa Medical University Asahikawa Japan
Tatsuya Hayashi: Department of Innovative Head & Neck Cancer Research and Treatment (IHNCRT) Asahikawa Medical University Asahikawa Japan
Yasuaki Harabuchi: Department of Otolaryngology‐Head & Neck Surgery Asahikawa Medical University Asahikawa Japan

Abstract

Abstract PD‐1 blockade is a feasible approach in treating mucosal malignant melanomas of the middle ear.